HALO logo
halo search icon
Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc.
ELVN · NAS

Enliven Therapeutics, Inc.

US$41.86

Price Arrow1.69 (4.21%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Earnings MomentumHALO MomentumHammer Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Enliven Therapeutics, Inc. Overview

ELVN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ELVN

icon

Telephone

1.720.647.8519

icon

Address

6200 Lookout Road, Boulder, CO 80301

Description

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.

ELVN Price Chart

Key Stats

Market Cap

US$2.45B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 14.78 - 48.53

Trade Value (12mth)

US$5,320,140.00

1 week

-2.83%

1 month

-12.46%

YTD

158.49%

1 year

137.27%

All time high

250.84

Key Fundamentals

EPS 3 yr Growth

-84.80%

EBITDA Margin

0.00%

Operating Cashflow

-$70m

Free Cash Flow Return

-18.30%

ROIC

-27.00%

Interest Coverage

0.00

Quick Ratio

28.70

Other Data

Shares Outstanding (Fully Diluted)

63m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ELVN Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

ELVN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.01-1.89-1.83locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.01-1.89-1.83locklocklock
Growth
%locklocklocklock83.36.13.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Enliven Therapeutics, Inc. (ELVN:NAS)?
Halo FAQ
The current share price of Enliven Therapeutics, Inc. (ELVN:NAS) is USD$41.86.
What is the 52-week high share price for Enliven Therapeutics, Inc. (ELVN:NAS)?
Halo FAQ
The 52-week high share price for Enliven Therapeutics, Inc. (ELVN:NAS) is USD$48.53.
What is the 52-week low share price for Enliven Therapeutics, Inc. (ELVN:NAS)?
Halo FAQ
The 52-week low share price for Enliven Therapeutics, Inc. (ELVN:NAS) is USD$14.78.
What is the dividend yield for Enliven Therapeutics, Inc. (ELVN:NAS)?
Halo FAQ
Enliven Therapeutics, Inc. (ELVN:NAS) does not pay a dividend.
What was Enliven Therapeutics, Inc. (ELVN:NAS) last dividend payment?
Halo FAQ
Enliven Therapeutics, Inc. (ELVN:NAS) does not pay a dividend.
What is the franking level for Enliven Therapeutics, Inc. (ELVN:NAS)?
Halo FAQ
Enliven Therapeutics, Inc. (ELVN:NAS) has a franking level of 0.00%.
In which sector is Enliven Therapeutics, Inc. (ELVN:NAS) classified?
Halo FAQ
Enliven Therapeutics, Inc. (ELVN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.